# A Study to Assess Food Effect of Venetoclax New Tablet Formulation in Healthy Female Participants

> **NCT06070948** · PHASE1 · WITHDRAWN · sponsor: **AbbVie**

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Venetoclax

## Key facts

- **NCT ID:** NCT06070948
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-10-05
- **Primary completion:** 2025-07-28
- **Final completion:** 2025-07-28
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Strategic considerations
- **Last updated:** 2024-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06070948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06070948, "A Study to Assess Food Effect of Venetoclax New Tablet Formulation in Healthy Female Participants". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06070948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*